Pharmaceutical company Novo Nordisk announced on Tuesday that it will be cutting prices of its insulin products amid competition and high scrutiny over insulin prices, prompting calls from progressive lawmakers for lowering the price of insulin products across the board. The company is lowering the prices of four of its insulin pens and vials by between 65 and 75 percent starting January 2024…
This post was originally published on Latest – Truthout.